

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.28212173 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.28212173 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.01098882 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01098882 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.76967714 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.55287323 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.24705112 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.92497559 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.92497559 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.92497559 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.86682908 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.73087156 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.63599158 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.58775307 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53100932 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 5.48290062 |
| 17 | cysteine metabolic process (GO:0006534) | 5.43477608 |
| 18 | urea metabolic process (GO:0019627) | 5.43081225 |
| 19 | urea cycle (GO:0000050) | 5.43081225 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.39290282 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.35721968 |
| 22 | omega-hydroxylase P450 pathway (GO:0097267) | 5.35693406 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.33986001 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.15604259 |
| 25 | protein carboxylation (GO:0018214) | 5.12205856 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.12205856 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.09276423 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.00571979 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.95002741 |
| 30 | lysine catabolic process (GO:0006554) | 4.93871867 |
| 31 | lysine metabolic process (GO:0006553) | 4.93871867 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.92424111 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91930100 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.84260948 |
| 35 | bile acid metabolic process (GO:0008206) | 4.84238468 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.81755698 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.79223470 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.75750620 |
| 39 | regulation of sequestering of triglyceride (GO:0010889) | 4.73540040 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.70198278 |
| 41 | low-density lipoprotein particle clearance (GO:0034383) | 4.68213430 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.65285870 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.63725213 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.62626022 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.62626022 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.62626022 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.61107153 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.60317374 |
| 49 | regulation of complement activation (GO:0030449) | 4.58130778 |
| 50 | triglyceride catabolic process (GO:0019433) | 4.57115487 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.53715855 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.53715855 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.46358294 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.46358294 |
| 55 | phospholipid efflux (GO:0033700) | 4.44247765 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.39681420 |
| 57 | oxaloacetate metabolic process (GO:0006107) | 4.38024102 |
| 58 | glycine metabolic process (GO:0006544) | 4.33459920 |
| 59 | ethanol metabolic process (GO:0006067) | 4.30897353 |
| 60 | polyketide metabolic process (GO:0030638) | 4.27911425 |
| 61 | doxorubicin metabolic process (GO:0044598) | 4.27911425 |
| 62 | daunorubicin metabolic process (GO:0044597) | 4.27911425 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.27469144 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.23625538 |
| 65 | neutral lipid catabolic process (GO:0046461) | 4.20037895 |
| 66 | acylglycerol catabolic process (GO:0046464) | 4.20037895 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.18339553 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.17544186 |
| 69 | regulation of plasminogen activation (GO:0010755) | 4.16145351 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.15980037 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.12623048 |
| 72 | amine catabolic process (GO:0009310) | 4.12623048 |
| 73 | ethanol oxidation (GO:0006069) | 4.12594709 |
| 74 | glutamate metabolic process (GO:0006536) | 4.10984240 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.07258412 |
| 76 | cellular glucuronidation (GO:0052695) | 4.06088283 |
| 77 | NADH metabolic process (GO:0006734) | 4.04468390 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 4.03883625 |
| 79 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.03423484 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 4.02449730 |
| 81 | fatty acid homeostasis (GO:0055089) | 4.02066170 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.01826012 |
| 83 | cholesterol efflux (GO:0033344) | 4.01332444 |
| 84 | ketone body metabolic process (GO:1902224) | 4.01071350 |
| 85 | drug metabolic process (GO:0017144) | 3.99501997 |
| 86 | drug catabolic process (GO:0042737) | 3.99402900 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 3.98389096 |
| 88 | response to mercury ion (GO:0046689) | 3.95837294 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 3.92488007 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90380743 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 3.89113623 |
| 92 | arginine metabolic process (GO:0006525) | 3.88825538 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.86372054 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.83519041 |
| 95 | organic acid catabolic process (GO:0016054) | 3.83519041 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81839642 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.80954161 |
| 98 | fibrinolysis (GO:0042730) | 3.80178303 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.75823640 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75705616 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74733682 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74733682 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.73915432 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 3.73294920 |
| 105 | primary alcohol catabolic process (GO:0034310) | 3.73028225 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.72272468 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 3.71166421 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.69786248 |
| 109 | fatty acid oxidation (GO:0019395) | 3.69023834 |
| 110 | oxidative demethylation (GO:0070989) | 3.68166452 |
| 111 | acute-phase response (GO:0006953) | 3.66890686 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.65850433 |
| 113 | monocarboxylic acid catabolic process (GO:0072329) | 3.65515765 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62766927 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62399118 |
| 116 | cofactor catabolic process (GO:0051187) | 3.62126542 |
| 117 | lipid oxidation (GO:0034440) | 3.61844703 |
| 118 | lipid storage (GO:0019915) | 3.61145418 |
| 119 | carnitine metabolic process (GO:0009437) | 3.61092305 |
| 120 | sterol homeostasis (GO:0055092) | 3.60511272 |
| 121 | creatine metabolic process (GO:0006600) | 3.59973093 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.59540857 |
| 123 | uronic acid metabolic process (GO:0006063) | 3.59397864 |
| 124 | glucuronate metabolic process (GO:0019585) | 3.59397864 |
| 125 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57989051 |
| 126 | phenylpropanoid metabolic process (GO:0009698) | 3.56024424 |
| 127 | fatty acid catabolic process (GO:0009062) | 3.55534111 |
| 128 | negative regulation of blood coagulation (GO:0030195) | 3.54004466 |
| 129 | negative regulation of hemostasis (GO:1900047) | 3.54004466 |
| 130 | primary alcohol metabolic process (GO:0034308) | 3.50494535 |
| 131 | biotin metabolic process (GO:0006768) | 3.38919880 |
| 132 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.36223699 |
| 133 | negative regulation of coagulation (GO:0050819) | 3.31045469 |
| 134 | positive regulation of lipid storage (GO:0010884) | 3.22992509 |
| 135 | valine metabolic process (GO:0006573) | 3.19283919 |
| 136 | fatty acid transmembrane transport (GO:1902001) | 3.18962405 |
| 137 | glycerolipid catabolic process (GO:0046503) | 3.15098905 |
| 138 | positive regulation of hemostasis (GO:1900048) | 3.13026042 |
| 139 | positive regulation of blood coagulation (GO:0030194) | 3.13026042 |
| 140 | protein activation cascade (GO:0072376) | 3.08752772 |
| 141 | negative regulation of wound healing (GO:0061045) | 3.07189380 |
| 142 | xenobiotic catabolic process (GO:0042178) | 3.05420007 |
| 143 | intestinal cholesterol absorption (GO:0030299) | 3.02046703 |
| 144 | positive regulation of coagulation (GO:0050820) | 2.97005553 |
| 145 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.94414412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25186233 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10535392 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.63290057 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38519266 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.77279764 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10145512 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.97537836 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96116575 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89360706 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58881385 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09301663 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00949470 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5822102 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83791128 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56187230 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46204632 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41232819 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40202758 |
| 19 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33022702 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30192984 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24614528 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20903115 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19297497 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13727923 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12903172 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12067374 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12048192 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07528049 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07462792 |
| 30 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05218378 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02833674 |
| 32 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02615391 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01642868 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99051706 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98010578 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97948058 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97182341 |
| 38 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.96788732 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96401119 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96315439 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93135169 |
| 42 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92820558 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92689299 |
| 44 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91178195 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91131521 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91053494 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91035397 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90422144 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89484472 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88570790 |
| 51 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88270128 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87688270 |
| 53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86933601 |
| 54 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85427618 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84383966 |
| 56 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83626489 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.83245894 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83092225 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 0.82699041 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81856325 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81549940 |
| 62 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81172675 |
| 63 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80720242 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80587567 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80292295 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79780295 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79629113 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78165499 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78110646 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77012700 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76002705 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75780449 |
| 73 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74472733 |
| 74 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.74462342 |
| 75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72957927 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72490214 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.70927251 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.70150323 |
| 79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.69824330 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69305785 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69275804 |
| 82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69267224 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68533187 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68526833 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68305777 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66050936 |
| 87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64268381 |
| 88 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63208905 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62943001 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62623012 |
| 91 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61739737 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61383761 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61383761 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60767826 |
| 95 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59777337 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57787900 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.57404891 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.56806373 |
| 99 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55042123 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54935590 |
| 101 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53712811 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53597313 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53572785 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52957017 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52633819 |
| 106 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52228432 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49786155 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.49601996 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.49601996 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48977025 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.48340112 |
| 112 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47785060 |
| 113 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45923007 |
| 114 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44331779 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.43659675 |
| 116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.43438905 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.42473727 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42472127 |
| 119 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.42276541 |
| 120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42004024 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.41027500 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40593089 |
| 123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40325650 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40238004 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40009639 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39973634 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39890257 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39137738 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38855468 |
| 130 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.38413150 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.37847606 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.37786633 |
| 133 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.37679268 |
| 134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37370470 |
| 135 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36180313 |
| 136 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36125594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15636041 |
| 2 | MP0005360_urolithiasis | 7.39639527 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13305199 |
| 4 | MP0005365_abnormal_bile_salt | 6.04268476 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93685315 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19130550 |
| 7 | MP0003252_abnormal_bile_duct | 3.67078744 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54710514 |
| 9 | MP0009840_abnormal_foam_cell | 3.37196502 |
| 10 | MP0005083_abnormal_biliary_tract | 3.00734449 |
| 11 | MP0003195_calcinosis | 2.94201585 |
| 12 | MP0005332_abnormal_amino_acid | 2.88675897 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.53651090 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.36303062 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.17920415 |
| 16 | MP0000609_abnormal_liver_physiology | 2.15672555 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.14264425 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.87066035 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.85930797 |
| 20 | MP0005451_abnormal_body_composition | 1.70127662 |
| 21 | MP0003868_abnormal_feces_composition | 1.69651118 |
| 22 | MP0000751_myopathy | 1.68665612 |
| 23 | MP0001764_abnormal_homeostasis | 1.63563869 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57551257 |
| 25 | MP0009697_abnormal_copulation | 1.49792785 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.45236882 |
| 27 | MP0004084_abnormal_cardiac_muscle | 1.43092760 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.42971594 |
| 29 | MP0000003_abnormal_adipose_tissue | 1.42116134 |
| 30 | MP0003959_abnormal_lean_body | 1.41534237 |
| 31 | MP0006138_congestive_heart_failure | 1.40906508 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.39113734 |
| 33 | MP0003186_abnormal_redox_activity | 1.39080011 |
| 34 | MP0005670_abnormal_white_adipose | 1.31214837 |
| 35 | MP0003011_delayed_dark_adaptation | 1.29288657 |
| 36 | MP0004087_abnormal_muscle_fiber | 1.27679920 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.27245893 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.18478265 |
| 39 | MP0000598_abnormal_liver_morphology | 1.15887003 |
| 40 | MP0000749_muscle_degeneration | 1.14926328 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.09783629 |
| 42 | MP0005647_abnormal_sex_gland | 1.09689312 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.08457710 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.08457710 |
| 45 | MP0004233_abnormal_muscle_weight | 1.07753498 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.06968145 |
| 47 | MP0000343_altered_response_to | 1.06047904 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.05152329 |
| 49 | MP0004130_abnormal_muscle_cell | 1.04087740 |
| 50 | MP0004510_myositis | 1.02238593 |
| 51 | MP0000604_amyloidosis | 1.01702352 |
| 52 | MP0002972_abnormal_cardiac_muscle | 0.99355509 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 0.98525029 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.98513035 |
| 55 | MP0009764_decreased_sensitivity_to | 0.97359038 |
| 56 | MP0009763_increased_sensitivity_to | 0.97196002 |
| 57 | MP0003828_pulmonary_edema | 0.96635632 |
| 58 | MP0003950_abnormal_plasma_membrane | 0.95750501 |
| 59 | MP0000750_abnormal_muscle_regeneration | 0.94953037 |
| 60 | MP0002254_reproductive_system_inflammat | 0.91134309 |
| 61 | MP0004215_abnormal_myocardial_fiber | 0.88805994 |
| 62 | MP0002971_abnormal_brown_adipose | 0.88684598 |
| 63 | MP0000759_abnormal_skeletal_muscle | 0.88149859 |
| 64 | MP0009642_abnormal_blood_homeostasis | 0.87491319 |
| 65 | MP0005408_hypopigmentation | 0.87328012 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 0.86187687 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.86061256 |
| 68 | MP0005620_abnormal_muscle_contractility | 0.84680182 |
| 69 | MP0008469_abnormal_protein_level | 0.83590323 |
| 70 | MP0000747_muscle_weakness | 0.82913488 |
| 71 | MP0010630_abnormal_cardiac_muscle | 0.81129128 |
| 72 | MP0002106_abnormal_muscle_physiology | 0.79985869 |
| 73 | MP0003879_abnormal_hair_cell | 0.79814700 |
| 74 | MP0001661_extended_life_span | 0.79037923 |
| 75 | MP0008775_abnormal_heart_ventricle | 0.78892684 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.78656842 |
| 77 | MP0005334_abnormal_fat_pad | 0.77423604 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.77233435 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.76120599 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.75620169 |
| 81 | MP0001756_abnormal_urination | 0.73659888 |
| 82 | MP0005535_abnormal_body_temperature | 0.73590044 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.72392114 |
| 84 | MP0009785_altered_susceptibility_to | 0.72383702 |
| 85 | MP0005164_abnormal_response_to | 0.72114832 |
| 86 | MP0005266_abnormal_metabolism | 0.70293610 |
| 87 | MP0005452_abnormal_adipose_tissue | 0.69018831 |
| 88 | MP0003718_maternal_effect | 0.66798511 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.66617088 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.65829502 |
| 91 | MP0005369_muscle_phenotype | 0.65754392 |
| 92 | MP0004484_altered_response_of | 0.64686841 |
| 93 | MP0003303_peritoneal_inflammation | 0.64361609 |
| 94 | MP0005165_increased_susceptibility_to | 0.63029057 |
| 95 | MP0003329_amyloid_beta_deposits | 0.62554270 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.62551236 |
| 97 | MP0005395_other_phenotype | 0.62402375 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.61718775 |
| 99 | MP0005023_abnormal_wound_healing | 0.61203044 |
| 100 | MP0003690_abnormal_glial_cell | 0.60136286 |
| 101 | MP0009053_abnormal_anal_canal | 0.58833145 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.58763255 |
| 103 | MP0003646_muscle_fatigue | 0.58125292 |
| 104 | MP0005448_abnormal_energy_balance | 0.57051094 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.55234109 |
| 106 | MP0009115_abnormal_fat_cell | 0.47677813 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.46771640 |
| 108 | MP0003953_abnormal_hormone_level | 0.46320213 |
| 109 | MP0005330_cardiomyopathy | 0.44257645 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.43551139 |
| 111 | MP0002970_abnormal_white_adipose | 0.41633255 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.41130307 |
| 113 | MP0002168_other_aberrant_phenotype | 0.41051978 |
| 114 | MP0002269_muscular_atrophy | 0.40830759 |
| 115 | MP0009672_abnormal_birth_weight | 0.40298373 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.40047123 |
| 117 | MP0008874_decreased_physiological_sensi | 0.39854670 |
| 118 | MP0002796_impaired_skin_barrier | 0.39604716 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.39484437 |
| 120 | MP0008873_increased_physiological_sensi | 0.39475666 |
| 121 | MP0002928_abnormal_bile_duct | 0.37506302 |
| 122 | MP0001881_abnormal_mammary_gland | 0.37102446 |
| 123 | MP0004043_abnormal_pH_regulation | 0.35968391 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.35459662 |
| 125 | MP0000579_abnormal_nail_morphology | 0.35116917 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.34695512 |
| 127 | MP0000249_abnormal_blood_vessel | 0.32614736 |
| 128 | MP0003724_increased_susceptibility_to | 0.32221211 |
| 129 | MP0002822_catalepsy | 0.32216754 |
| 130 | MP0003075_altered_response_to | 0.32117803 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.31414419 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.29947420 |
| 133 | MP0001853_heart_inflammation | 0.29307957 |
| 134 | MP0008872_abnormal_physiological_respon | 0.28462875 |
| 135 | MP0005166_decreased_susceptibility_to | 0.26822532 |
| 136 | MP0002135_abnormal_kidney_morphology | 0.26214284 |
| 137 | MP0002060_abnormal_skin_morphology | 0.26004563 |
| 138 | MP0003436_decreased_susceptibility_to | 0.25356539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.05381500 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.04434802 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.81919908 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.22333426 |
| 5 | Xanthomatosis (HP:0000991) | 6.10449261 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.01482603 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.99094571 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.46608349 |
| 9 | Complement deficiency (HP:0004431) | 4.84079479 |
| 10 | Hyperammonemia (HP:0001987) | 4.82206557 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.69923762 |
| 12 | Hyperglycinemia (HP:0002154) | 4.66112317 |
| 13 | Ketosis (HP:0001946) | 4.54888222 |
| 14 | Hyperglycinuria (HP:0003108) | 4.52512845 |
| 15 | Joint hemorrhage (HP:0005261) | 4.45706030 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.35232166 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.35232166 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.30567783 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.28527802 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.24915874 |
| 21 | Epidermoid cyst (HP:0200040) | 4.23075665 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15611183 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14741650 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13957129 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.08028256 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07396625 |
| 27 | Fat malabsorption (HP:0002630) | 3.84412080 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79474999 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59161965 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.58669365 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.53987061 |
| 32 | Ketoacidosis (HP:0001993) | 3.50904629 |
| 33 | Abnormality of complement system (HP:0005339) | 3.49093924 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.48291980 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.32896648 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 3.25810821 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.19115894 |
| 38 | Hypertriglyceridemia (HP:0002155) | 3.14977493 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14796889 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.14051281 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.06977706 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06977706 |
| 43 | Oligomenorrhea (HP:0000876) | 3.03796551 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.98360880 |
| 45 | Muscle fiber inclusion bodies (HP:0100299) | 2.97070270 |
| 46 | Myocardial infarction (HP:0001658) | 2.96220639 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.95201803 |
| 48 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.94968128 |
| 49 | Metabolic acidosis (HP:0001942) | 2.94820112 |
| 50 | Steatorrhea (HP:0002570) | 2.91196496 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.89271070 |
| 52 | Lethargy (HP:0001254) | 2.87102694 |
| 53 | Nemaline bodies (HP:0003798) | 2.87069157 |
| 54 | Rhabdomyolysis (HP:0003201) | 2.86587082 |
| 55 | Gout (HP:0001997) | 2.85783738 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.85303902 |
| 57 | Exercise-induced myalgia (HP:0003738) | 2.83856020 |
| 58 | Spontaneous abortion (HP:0005268) | 2.76560953 |
| 59 | Skin nodule (HP:0200036) | 2.72432145 |
| 60 | Cerebral edema (HP:0002181) | 2.67373217 |
| 61 | Vascular calcification (HP:0004934) | 2.62937023 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.58151493 |
| 63 | Acanthosis nigricans (HP:0000956) | 2.57639262 |
| 64 | Nephritis (HP:0000123) | 2.56116037 |
| 65 | Myoglobinuria (HP:0002913) | 2.51303609 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.50501514 |
| 67 | Hyporeflexia of lower limbs (HP:0002600) | 2.47006818 |
| 68 | Generalized aminoaciduria (HP:0002909) | 2.46848258 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 2.45004856 |
| 70 | Distal lower limb muscle weakness (HP:0009053) | 2.44943687 |
| 71 | Atrioventricular block (HP:0001678) | 2.39167107 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.38700774 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.38446529 |
| 74 | Increased connective tissue (HP:0009025) | 2.38127299 |
| 75 | Neck muscle weakness (HP:0000467) | 2.38045740 |
| 76 | Cholelithiasis (HP:0001081) | 2.35495238 |
| 77 | EMG: myopathic abnormalities (HP:0003458) | 2.34821563 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.34299351 |
| 79 | Type 1 muscle fiber predominance (HP:0003803) | 2.32654886 |
| 80 | Spastic diplegia (HP:0001264) | 2.32137663 |
| 81 | Irritability (HP:0000737) | 2.32014691 |
| 82 | Malnutrition (HP:0004395) | 2.30726147 |
| 83 | Vomiting (HP:0002013) | 2.28361661 |
| 84 | Neonatal onset (HP:0003623) | 2.28190710 |
| 85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27810154 |
| 86 | Increased serum pyruvate (HP:0003542) | 2.26867432 |
| 87 | Late onset (HP:0003584) | 2.26724592 |
| 88 | Mitral stenosis (HP:0001718) | 2.23383233 |
| 89 | Glomerulonephritis (HP:0000099) | 2.22640377 |
| 90 | Sudden death (HP:0001699) | 2.21233325 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20642704 |
| 92 | Acanthocytosis (HP:0001927) | 2.20567434 |
| 93 | Bundle branch block (HP:0011710) | 2.20253830 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.19397750 |
| 95 | Pancreatitis (HP:0001733) | 2.19342128 |
| 96 | Brushfield spots (HP:0001088) | 2.15649824 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14751690 |
| 98 | Esophageal varix (HP:0002040) | 2.13859788 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 2.13147151 |
| 100 | Cholecystitis (HP:0001082) | 2.13147151 |
| 101 | Abnormal atrioventricular conduction (HP:0005150) | 2.11823787 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 2.09808613 |
| 103 | Hyperalaninemia (HP:0003348) | 2.09808613 |
| 104 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.09808613 |
| 105 | Heart block (HP:0012722) | 2.09769759 |
| 106 | Proximal tubulopathy (HP:0000114) | 2.08730427 |
| 107 | Amyloidosis (HP:0011034) | 2.08694977 |
| 108 | Cerebral palsy (HP:0100021) | 2.07714965 |
| 109 | Hydroxyprolinuria (HP:0003080) | 2.06647351 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 2.06647351 |
| 111 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.05774512 |
| 112 | Increased purine levels (HP:0004368) | 2.03601338 |
| 113 | Hyperuricemia (HP:0002149) | 2.03601338 |
| 114 | Rimmed vacuoles (HP:0003805) | 2.03268795 |
| 115 | Enlarged kidneys (HP:0000105) | 2.02989168 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 2.02967385 |
| 117 | Ragged-red muscle fibers (HP:0003200) | 2.01775011 |
| 118 | Renal cortical cysts (HP:0000803) | 2.00765727 |
| 119 | Insulin resistance (HP:0000855) | 2.00619442 |
| 120 | Lipoatrophy (HP:0100578) | 1.99394671 |
| 121 | Upper motor neuron abnormality (HP:0002127) | 1.98777147 |
| 122 | Hyperglycemia (HP:0003074) | 1.98500775 |
| 123 | Abnormality of glycolysis (HP:0004366) | 1.97104598 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96737537 |
| 125 | Mucopolysacchariduria (HP:0008155) | 1.96737537 |
| 126 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94326860 |
| 127 | Abnormality of the gallbladder (HP:0005264) | 1.93973012 |
| 128 | Opisthotonus (HP:0002179) | 1.93595910 |
| 129 | Thrombophlebitis (HP:0004418) | 1.93328980 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.93100704 |
| 131 | Menorrhagia (HP:0000132) | 1.93038398 |
| 132 | Gingival bleeding (HP:0000225) | 1.92813666 |
| 133 | Achilles tendon contracture (HP:0001771) | 1.92806380 |
| 134 | Difficulty running (HP:0009046) | 1.92664927 |
| 135 | Nausea (HP:0002018) | 1.92284438 |
| 136 | Back pain (HP:0003418) | 1.91885926 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90086617 |
| 138 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89940111 |
| 139 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89940111 |
| 140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89940111 |
| 141 | Increased serum ferritin (HP:0003281) | 1.89097425 |
| 142 | Stroke (HP:0001297) | 1.88872140 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 1.87728820 |
| 144 | Glycosuria (HP:0003076) | 1.87728820 |
| 145 | Axonal loss (HP:0003447) | 1.87663704 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87528107 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.87436979 |
| 148 | Polycythemia (HP:0001901) | 1.86495516 |
| 149 | Rickets (HP:0002748) | 1.86275459 |
| 150 | Bulbar palsy (HP:0001283) | 1.85972080 |
| 151 | Elevated hepatic transaminases (HP:0002910) | 1.80988217 |
| 152 | Alkalosis (HP:0001948) | 1.80567950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.54264671 |
| 2 | SIK1 | 4.38724913 |
| 3 | FGFR4 | 3.95965084 |
| 4 | ERN1 | 3.95165653 |
| 5 | TAOK3 | 2.79098254 |
| 6 | PKN2 | 2.73137988 |
| 7 | INSRR | 2.67843804 |
| 8 | PRPF4B | 2.66826639 |
| 9 | RIPK4 | 2.64736913 |
| 10 | TRIB3 | 2.61719104 |
| 11 | ERBB4 | 2.48504179 |
| 12 | LATS1 | 2.22404770 |
| 13 | FLT3 | 1.99294874 |
| 14 | MST1R | 1.98560698 |
| 15 | STK38L | 1.95486182 |
| 16 | MAP2K4 | 1.83292999 |
| 17 | PINK1 | 1.74098954 |
| 18 | PIK3CG | 1.69783534 |
| 19 | EEF2K | 1.67352953 |
| 20 | MAPK11 | 1.64033289 |
| 21 | ABL2 | 1.49239267 |
| 22 | PHKG2 | 1.46639248 |
| 23 | PHKG1 | 1.46639248 |
| 24 | MAPKAPK3 | 1.45473726 |
| 25 | TYK2 | 1.45374213 |
| 26 | NEK9 | 1.39250878 |
| 27 | TRPM7 | 1.34483951 |
| 28 | PDK3 | 1.32359576 |
| 29 | PDK4 | 1.32359576 |
| 30 | PRKAA2 | 1.32138568 |
| 31 | PTK6 | 1.28425208 |
| 32 | FRK | 1.25352286 |
| 33 | MUSK | 1.24872549 |
| 34 | KDR | 1.19693850 |
| 35 | NME2 | 1.16048084 |
| 36 | MAP3K1 | 1.11076733 |
| 37 | DAPK2 | 1.08026745 |
| 38 | CAMK1D | 1.07295045 |
| 39 | MAP2K3 | 1.05261921 |
| 40 | MOS | 1.03963857 |
| 41 | JAK2 | 1.03461485 |
| 42 | IRAK3 | 1.02357738 |
| 43 | TIE1 | 0.98964941 |
| 44 | DDR2 | 0.98201089 |
| 45 | MAP3K7 | 0.96642107 |
| 46 | MAP3K3 | 0.96626031 |
| 47 | GRK7 | 0.95281795 |
| 48 | BMPR2 | 0.90895761 |
| 49 | FGFR2 | 0.89533360 |
| 50 | LATS2 | 0.88477997 |
| 51 | PRKAA1 | 0.88302399 |
| 52 | TESK1 | 0.86528402 |
| 53 | TBK1 | 0.85696210 |
| 54 | EPHB2 | 0.84767227 |
| 55 | JAK1 | 0.83585321 |
| 56 | MAPK12 | 0.83032249 |
| 57 | MAP3K6 | 0.79985979 |
| 58 | MET | 0.77690542 |
| 59 | RPS6KB2 | 0.76926013 |
| 60 | EPHA3 | 0.74777598 |
| 61 | MAPK4 | 0.74054295 |
| 62 | ARAF | 0.72894576 |
| 63 | PRKCZ | 0.71588996 |
| 64 | RIPK1 | 0.71403609 |
| 65 | MAP3K11 | 0.70729852 |
| 66 | PRKACG | 0.70242412 |
| 67 | EPHB1 | 0.68897069 |
| 68 | ERBB2 | 0.67786095 |
| 69 | PIK3CA | 0.66941838 |
| 70 | PDK2 | 0.65791819 |
| 71 | JAK3 | 0.65317724 |
| 72 | GRK6 | 0.65187582 |
| 73 | PRKD3 | 0.63271442 |
| 74 | CDK6 | 0.62955816 |
| 75 | MAP3K5 | 0.59933545 |
| 76 | BMX | 0.58556144 |
| 77 | NEK1 | 0.57995856 |
| 78 | DMPK | 0.57951225 |
| 79 | AKT2 | 0.57776113 |
| 80 | ADRBK1 | 0.57216607 |
| 81 | DAPK3 | 0.56442398 |
| 82 | GSK3A | 0.56399292 |
| 83 | DYRK1B | 0.56166274 |
| 84 | ILK | 0.55817073 |
| 85 | PDPK1 | 0.55613838 |
| 86 | CAMK2G | 0.55601401 |
| 87 | ADRBK2 | 0.55413763 |
| 88 | SGK3 | 0.54862743 |
| 89 | MAP3K10 | 0.54832515 |
| 90 | ZAP70 | 0.54594797 |
| 91 | TGFBR2 | 0.53857182 |
| 92 | IKBKB | 0.53650223 |
| 93 | CAMK1 | 0.52377840 |
| 94 | LRRK2 | 0.51903597 |
| 95 | TTN | 0.51851905 |
| 96 | PTK2 | 0.51395308 |
| 97 | RPS6KC1 | 0.51225908 |
| 98 | RPS6KL1 | 0.51225908 |
| 99 | MYLK | 0.51108468 |
| 100 | STK38 | 0.49462548 |
| 101 | MAP2K6 | 0.49330103 |
| 102 | TAOK2 | 0.49246928 |
| 103 | MAP2K1 | 0.48745558 |
| 104 | CDC42BPA | 0.48127473 |
| 105 | MAP3K14 | 0.45594409 |
| 106 | STK3 | 0.45161110 |
| 107 | TAOK1 | 0.44882821 |
| 108 | CAMK1G | 0.44771901 |
| 109 | CDK4 | 0.43788499 |
| 110 | RPS6KA6 | 0.43778531 |
| 111 | CSK | 0.43418484 |
| 112 | MTOR | 0.43343745 |
| 113 | PRKG1 | 0.43081337 |
| 114 | PAK3 | 0.40820760 |
| 115 | MAPK15 | 0.40645998 |
| 116 | OBSCN | 0.40322809 |
| 117 | SGK2 | 0.39500773 |
| 118 | EIF2AK2 | 0.39188458 |
| 119 | FGFR3 | 0.38665468 |
| 120 | SCYL2 | 0.38356390 |
| 121 | IGF1R | 0.38345711 |
| 122 | CSNK1G1 | 0.36696414 |
| 123 | RET | 0.36409584 |
| 124 | MAPK7 | 0.36217974 |
| 125 | CSF1R | 0.34978222 |
| 126 | PDK1 | 0.33683187 |
| 127 | MAP3K13 | 0.30590230 |
| 128 | PRKCQ | 0.30001233 |
| 129 | SGK494 | 0.28920955 |
| 130 | SGK223 | 0.28920955 |
| 131 | LMTK2 | 0.28769224 |
| 132 | IKBKE | 0.27244733 |
| 133 | EPHA2 | 0.26256420 |
| 134 | AKT3 | 0.25887836 |
| 135 | KSR2 | 0.25285164 |
| 136 | PRKD1 | 0.24920045 |
| 137 | PDGFRA | 0.21526118 |
| 138 | GRK1 | 0.21283415 |
| 139 | CAMK4 | 0.21128650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.19144048 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31822525 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31654237 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25607892 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94464708 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74666916 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68178599 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67133845 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66267631 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62932821 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51726565 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50209081 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27780201 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24581969 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22641712 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.12034109 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09346670 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00396790 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97007585 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90302736 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88947686 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82215343 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80965165 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80093433 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79304164 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70938972 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70159501 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69272145 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67102300 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65759955 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61580504 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58550796 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54795522 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53356081 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51180028 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47969712 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.42991237 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40239003 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37260146 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35710868 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31451279 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30499236 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29179454 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27444831 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25965425 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18814388 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.10341545 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09290915 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04008116 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03580962 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03518544 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97049581 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96883561 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93715626 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93581008 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93040134 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89471678 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87696758 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87402819 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.85427580 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85239748 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78591074 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78003521 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71041918 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70030707 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69011129 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68453719 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63530120 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49663866 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41469460 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32242325 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31508483 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.30506886 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30286706 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28614929 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.28102472 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27157469 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21756817 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21565816 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.20353700 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20172883 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16190627 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13665459 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.11756279 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09992054 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09620686 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.04100712 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.03373629 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00148368 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | -0.2506934 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2401913 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2366770 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2350282 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | -0.2323809 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2251574 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.2146940 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2018166 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1841395 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1787727 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1691583 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1674237 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1667026 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1628766 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1260094 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1139331 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0798314 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0626866 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0510940 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0357768 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0187083 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0180205 |
| 112 | Lysosome_Homo sapiens_hsa04142 | -0.0094127 |

